Portale, Federica
22  results:
Search for persons X
?
1

NK Cells in Cancer: Mechanisms of Dysfunction and Therapeut..:

Portale, Federica ; Di Mitri, Diletta
International Journal of Molecular Sciences.  24 (2023)  11 - p. 9521 , 2023
 
?
3

Lipid-loaded macrophages as new therapeutic target in cance:

Marelli, Giulia ; Morina, Nicolò ; Portale, Federica...
Journal for ImmunoTherapy of Cancer.  10 (2022)  7 - p. e004584 , 2022
 
?
 
?
13

Impact of APOL1 polymorphism and IL-1β priming in the entry..:

Mikulak, Joanna ; Oriolo, Ferdinando ; Portale, Federica...
Mikulak , J , Oriolo , F , Portale , F , Tentorio , P , Lan , X , Saleem , M A , Skorecki , K , Singhal , P C & Mavilio , D 2016 , ' Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes ' , Retrovirology , vol. 13 , no. 1 , pp. 63 . https://doi.org/10.1186/s12977-016-0296-3.  , 2016
 
?
14

Full-length soluble urokinase plasminogen activator recepto..:

Alfano, Massimo ; Cinque, Paola ; Giusti, Guido...
Alfano , M , Cinque , P , Giusti , G , Proietti , S , Nebuloni , M , Danese , S , D'Alessio , S , Genua , M , Portale , F , Lo Porto , M , Singhal , P C , Rastaldi , M P , Saleem , M A , Mavilio , D & Mikulak , J 2015 , ' Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes ' , Scientific Reports , vol. 5 , 13647 . https://doi.org/10.1038/srep13647.  , 2015
 
?
 
1-15